Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

207.57 USD -5.15 (-2.42%)
Official Closing Price Updated: 6:30 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Eli Lilly

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Regeneron Requests Emergency Use Authorization, Analysts See Coronavirus Antibodies As Earnings Driver In 2021
Regeneron Pharmaceuticals Inc (NASDAQ: REGN)saidWednesday that it requested emergency use authorization from the FDA for its ... 
Tags FDA Top Stories Price Target
From Benzinga
Trump’s vaccine czar says the first vaccine should be submitted for emergency authorization around Thanksgiving
Moncef Slaoui, an immunologist by training and a longtime pharmaceutical executive, is running the Trump administration’s Operation Warp Speed program to spur development of vaccines on the fastest... 
Tags CVS BNTX MRK
From MarketWatch
Cramer Doesn't Like Buying Regeneron's Stock Just Because Of Trump Treatment
U.S. President Donald Trump receiving treatment for COVID-19 from Regeneron Pharmaceuticals Inc (NASDAQ: REGN) isn't reason enough ... 
Tags Benzinga Health Care Coronavirus
From Benzinga
Noteworthy ETF Inflows: MTUM, AMZN, LLY, DHR
Symbols mentioned in this story: MTUM, AMZN, LLY, DHR Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
McDonald's Setting the Tone Early As Strong Same-Store Sales Hint At Folks Going Back To Work
If there were one word to describe market activity this week, it might be “shrug.” From the on-again-off-again stimulus ... 
Tags TD Ameritrade Markets Market News
From Benzinga
Coronavirus update: New England Journal of Medicine says Trump should be voted out over pandemic management as U.S. death toll nears 212,000
The U.S. death toll from the coronavirus illness COVID-19 moved closer to 212,000 on Thursday, as the editors of the prestigious New England Journal of Medicine sharply criticized the Trump... 
Tags Health/Care MRNA MA
From MarketWatch
Covid Report: Regeneron Pharmaceuticals Files For Emergency Authorization; Gilead Inks European Supply Deal
Regeneron Pharmaceuticals, boosted by an endorsement from President Trump, filed for emergency authorization for its Covid-19 drug therapy, while Gilead Sciences inked European supply deal. 
From Investor's Business Daily
Regeneron Rallies After Seeking Emergency-Use Approval For Antibody Cocktail Hailed As "Cure" By Trump
Shares of Regeneron are ripping higher Thursday in premarket trading, building on its gains from Wednesday evening, after the company submitted its COVID-19 antibody cocktail to the FDA for... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
The Daily Biotech Pulse: Gilead, Lilly COVID-19 Treatment Supply Agreements, CareDx's Positive Preannouncement, Aziyo Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ONCR TGTX NVCR
From Benzinga
Junshi and Lilly to File for Emergency Use of Paired Antibodies for COVID-19
Junshi Bio of Shanghai and Lilly released positive interim data on their paired antibody treatment for COVID-19. In early results from a Phase II trial, the combination reduced viral load, symptoms and... 
From ChinaBio® Today
4 Top ETFs, Stocks From Attractive Sectors Pre Q3 Earnings
Here are one ETF and one stock from the sectors that could make great plays as the earnings season unfolds. 
Tags Stocks / Equities ETFs
From Blogs - TalkMarkets
Trump Touts Regeneron Antibody Cocktail As 'Cure,' Says 'I Felt Good Immediately'
President Donald Trump touted Regeneron Pharmaceuticals Inc’s (NASDAQ: REGN) antibody cocktail as a "cure" for COVID-19 ... 
Tags Biotech Antibodies Donald Trump
From Benzinga
Noteworthy Wednesday Option Activity: LLY, HELE, DRI
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Lilly (Eli) & Co (LLY), where a total of 23,882 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Eli Lilly Rallies On EUA Request For COVID-19 Antibody Monotherapy, Promising Antibody Cocktail Data
Eli Lilly And Co (NYSE: LLY) shares are advancing Wednesday after the company issued an update on its anti-COVID-19 antibody ... 
Tags Top Stories Biotech Covid/19
From Benzinga
Eli Lilly Requests Emergency Use Authorization for COVID-19 Treatment Candidate
New clinical trial data strongly suggests treatment with its antibody therapies makes a big difference for COVID-19 positive patients. 
Tags LLY Market News
From Motley Fool
Dow Jones Rallies 400 Points On Trump Tweet After Tuesday's Market Meltdown
The Dow Jones Industrial Average held near session highs midday, after President Trump's latest tweet sent stocks soaring one day after sinking. 
From Investor's Business Daily
Coronavirus update: U.S. death toll nears 211,000 as doctors caution that Trump is entering a key phase in his diagnosis
The U.S. death toll from the coronavirus illness COVID-19 edged closer to 211,000 on Wednesday, as doctors and medical experts said President Donald Trump is entering a key phase in the illness which... 
Tags Health/Care LOW LEVI
From MarketWatch
Return On Capital Employed Overview: Eli Lilly
Eli Lilly (NYSE: LLY) posted Q2 earnings of $1.20 billion, an increase from Q1 of 24.77%. Sales dropped to $5.50 billion, a 6.16% ... 
Tags Market News LLY Benzinga
From Benzinga
Eli Lilly Files Emergency Use Authorization Request For A Covid-19 Therapy
Eli Lilly said it filed an initial request for emergency use authorization for its Covid-19 treatment with the FDA, and said it could have 1 million doses of its treatment this quarter. 
From Investor's Business Daily
Why Sorrento Therapeutics Stock Bolted Higher in September
Sorrento's stock outperformed the broader biotech industry by a wide margin last month. 
Tags LLY Market News IBB
From Motley Fool
Bill Gates Says Regulatory Approval For Antibody Drugs Could Sharply Reduce COVID-19 Mortality
Antibody drugs currently undergoing testing could be a panacea for the COVID-19 pandemic ravaging the world once they get regulatory ... 
Tags Antibodies Biotech The Wall Street Journal
From Benzinga
The FDA Just Ranked Coronavirus Tests by Sensitivity. Here's What That Means
You know what they say! To the most sensitive tests go the spoils. 
Tags QGEN BDX Market News
From Motley Fool
Trump’s coronavirus diagnosis underscores lack of treatment options for people with mild forms of COVID-19
There are a limited number of treatment options for people who test positive for COVID-19, though most available therapies have only proven to be effective in people with severe forms of the disease. 
Tags Medical Products Health/Care General
From MarketWatch
An experimental antibody treatment reduced viral load in some COVID-19 patients. That may also be a positive sign for vaccines
Promising new clinical data for an experimental COVID-19 treatment hints at a secondary but possibly more important takeaway for investors: if this neutralizing antibody treatment works, so will the... 
Tags Health/Care UK:AZN Medical Products
From MarketWatch
Notable ETF Inflow Detected - MTUM, AMZN, LLY, DHR
Symbols mentioned in this story: MTUM, AMZN, LLY, DHR Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Covid Report: Regeneron, Moderna, CureVac Up As Possible Coronavirus Cures Advance
Regeneron Pharmaceuticals stock rose on positive data on its possible Covid-19 treatment, while shares of Moderna and CureVac stock rose as their possible Covid-19 vaccines made advances. 
From Investor's Business Daily
Regeneron Says COVID-19 Antibody Cocktail Helped Non-Hospitalized Patients Heal Faster In Early Trials
Regeneron Pharmaceuticals, Inc(NASDAQ: REGN) announced Tuesday that its antibody cocktail drug showed positive effects in ... 
Tags AZN PFE Events
From Benzinga
Regeneron Pharmaceutical Posts Positive Initial Data On Its Covid-19 Treatment
Regeneron Pharmaceutical posted positive data from its Covid-19 treatment trials; an announcement that came after the close of Tuesday's regular session but could spark REGN stock. 
From Investor's Business Daily
Eli Lilly Breaks Below 200-Day Moving Average - Notable for LLY
In trading on Tuesday, shares of Lilly (Eli) & Co (LLY) crossed below their 200 day moving average of $147.36, changing hands as low as $147.33 per share. Lilly (Eli) & Co shares are currently trading... 
Tags Stocks
From Market News Video
Benzinga's Top Upgrades, Downgrades For September 29, 2020
Upgrades Argus Research upgraded the previous rating for Darden Restaurants Inc (NYSE: DRI) from Hold to Buy. For the first ... 
Tags Initiation MGNI STAY
From Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.